This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on ISI (3)  • Contact me when this article is cited  Related Content  • Similar articles in this journal

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Alopecia universalis (AU) is a disease characterized by a nonscarring, total body hair loss of unknown etiology. It is associated with other autoimmune diseases and serum autoantibodies, and abnormalities on complement function are sometimes detected.^1-2 In this article, we relate a case of persistent hair regrowth following high-dose chemotherapy and autologous stem cell transplantation (ASCT) for a non-Hodgkin lymphoma in a patient with extensive AU.

Report of a Case

A 48-year-old man was referred to our service in August 1997 with a follicular lymphoma (Ann Arbor stage IIIB), diagnosed in July 1995, that was refractory to chemotherapy. He had been extensively pretreated with different chemotherapy regimens such as BACOP (bleomycin, doxorubicin, cyclophosphamide, vincristine, and prednisone), MINE (ifosfamide, mitoxantrone, and etoposide), and DHAP (dexamethasone, cytarabine, and cisplatin). He also reported a long-lasting history of AU since age 19 years (Figure 1). He had been treated with topical and systemic corticosteroids and minoxidil without . . . [Full Text of this Article]

Comment

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Complete remission of alopecia universalis after allogeneic hematopoietic stem cell transplantation
Seifert et al.
Blood 2005;105:426-427.
ABSTRACT | FULL TEXT